STOCK TITAN

Arq Inc 10-Q Filings

ARQ NASDAQ

Every 10-Q that Arq Inc (ARQ) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow ARQ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ARQ filings page.

Rhea-AI Summary

Arq, Inc. reported modestly higher sales but remained unprofitable for the quarter and first half of 2026. For the three months ended June 30, 2026, revenue was $29.9 million versus $28.6 million a year earlier, while net loss narrowed to $0.7 million from $2.4 million. For the six months, revenue reached $58.9 million with a net loss of $1.9 million, improving from a $2.4 million loss in 2025.

Cost controls and mix helped margins: three‑month cost of revenue excluding depreciation fell to $18.4 million from $19.1 million, aided by idling the Corbin facility and lower sales of lower‑margin chemicals. Adjusted EBITDA rose to $5.8 million for the quarter and $8.6 million year‑to‑date. The company changed its turnaround accounting to a deferral method, increasing June 30, 2026 retained earnings by $1.6 million versus the prior method.

Liquidity is tight with $0.9 million of cash and $11.2 million of restricted cash against $30.7 million of debt, including $21.4 million drawn on a $30 million revolving facility. Arq has paused GAC production and expects no GAC output in 2026 or 2027 while an optimization and redesign review continues; litigation with the former GAC design firm is ongoing. Management expects existing cash and revolver availability to fund operations for the next 12 months.

Rhea-AI Summary

Arq, Inc. reported first-quarter 2026 revenue of $29.1 million, up from $27.2 million a year earlier, but swung to a net loss of $0.8 million versus net income of $0.2 million. Higher sales volumes were offset by weaker pricing, more lower‑margin chemical sales and GAC-related costs.

Cost of revenue rose to $19.1 million, compressing gross margin. Adjusted EBITDA declined to $2.7 million from $4.1 million. Arq paused GAC production and continues to idle its Corbin Facility while an engineering and economics review is completed, and now does not expect any GAC production in 2026.

At March 31, 2026, Arq held $4.7 million of cash plus $11.2 million of restricted cash, with total debt of about $30.2 million, including $20.9 million drawn on its Revolving Credit Facility. Operating cash flow was slightly positive at $0.1 million, and management believes cash and credit availability can fund operations for the next 12 months.

Rhea-AI Summary

Arq, Inc. reported Q3 2025 results, with revenue of $35.1 million versus $34.8 million a year ago, and a net loss of $0.7 million compared to net income of $1.6 million. For the first nine months, revenue rose to $90.9 million from $81.9 million as pricing and volumes improved.

Margins were pressured by initial commercial production at the Red River GAC facility, lifting cost of revenue and depreciation, while selling, general and administrative costs fell. Cash was $7.0 million, restricted cash $8.5 million, and revolver borrowings were $16.0 million as of September 30, 2025. Total liabilities were $60.8 million and stockholders’ equity was $217.2 million. As of November 3, 2025, 42,693,884 common shares were outstanding.

Rhea-AI Summary

Arq, Inc. (ARQ) reported revenue growth driven by higher volumes and pricing as demand from coal-fired power customers rose with higher natural gas prices. Quarterly revenue was $28.6 million (up 13% year-over-year) and year-to-date revenue was $55.8 million (up 18%). The company recorded a net loss of $2.1 million for the quarter and $1.9 million year-to-date, with loss per share of $(0.05) for the quarter and $(0.05) for six months.

Adjusted EBITDA improved to $3.7 million for the quarter and $7.7 million year-to-date, reflecting higher pricing and contributions from product mix, partially offset by increased R&D related to pre-production testing of the new GAC Facility. Cash and restricted cash totaled $15.4 million at period end (cash $6.96 million; restricted cash $8.47 million). Total assets were $284.5 million and stockholders' equity was $216.8 million. The company has a $30.0 million secured revolving credit facility with $18.5 million outstanding at quarter-end and reported $8.5 million of cash collateral pledged for surety bonds. Management completed commissioning of the Red River Plant expansion in August 2025 and reported ongoing Corbin Facility activity and mine assets supplying feedstock.